MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, S. L.
Right arrow Articles by Brown, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, S. L.
Right arrow Articles by Brown, J. H.

Muscarinic stimulation of phosphatidylinositol metabolism in atria

SL Brown and JH Brown

Phosphatidylinositol (PtdIns) turnover in murine atria is stimulated by the cholinergic agonist carbachol. Incorporation of either [32P]phosphate or [myo-3H]inositol into PtdIns is increased 40-80% by 30 microM carbachol, but carbachol does not increase the labeling of other major phospholipids. Cholinergic stimulation of PtdIns synthesis is blocked by the muscarinic antagonist atropine. When Ca2+ is removed from the extracellular medium, there is a large increase in basal PtdIns synthesis, and carbachol does not produce any further increase in [32P]phosphate incorporation. Carbachol also stimulates hydrolysis of phosphoinositides as measured by myo[3H]inositol 1-phosphate accumulation. A maximal concentration of carbachol causes a 300-400% increase in phosphoinositide breakdown, and half-maximal stimulation occurs at a carbachol concentration of approximately 10 microM. Muscarinic stimulation of inositol phospholipid hydrolysis is seen in left and right atria as well as in ventricular tissue. The effect of carbachol on phosphoinositide hydrolysis is markedly attenuated when extracellular Ca2+ is removed. In contrast to most other hormone receptors linked to PtdIns metabolism, there is no evidence that cardiac muscarinic receptors mediate their physiological effects through Ca2+ mobilization. Thus, receptor-mediated changes in PtdIns turnover may serve a different function in the heart than in hormone- receptor systems that utilize Ca2+ as a second messenger.

Volume 24, Issue 3, pp. 351-356, 11/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
U. Mende, A. Kagen, A. Cohen, J. Aramburu, F. J. Schoen, and E. J. Neer
Transient cardiac expression of constitutively active Galpha q leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways
PNAS, November 10, 1998; 95(23): 13893 - 13898.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Y. G. Wang and S. L. Lipsius
ß-Adrenergic Stimulation Induces Acetylcholine to Activate ATP-Sensitive K+ Current in Cat Atrial Myocytes
Circ. Res., September 1, 1995; 77(3): 565 - 574.
[Abstract] [Full Text]

Home page
 ScienceHome page
Y Kloog, I Ambar, M Sokolovsky, E Kochva, Z Wollberg, and A Bdolah
Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain
Science, October 14, 1988; 242(4876): 268 - 270.
[Abstract] [PDF]

Home page
 ScienceHome page
H. Lester
Heterologous expression of excitability proteins: route to more specific drugs?
Science, August 26, 1988; 241(4869): 1057 - 1063.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics